Antipodes Partners Ltd

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-06
Total Holdings
102
Total Value
3193074544
Accession Number
0001652442-25-000003
Form Type
13F-HR
Manager Name
Antipodes Partners Ltd
Data Enrichment
95% identified
97 identified5 unidentified

Holdings

102 positions
Manager:
Search and click to pin securities to the top
ABBOTT LABORATORIES
Shares:
1270
Value:
$168.5M
MOSAIC CO
Shares:
5575(+76.1%)
Value:
$150.6M(+93.5%)
QUEST DIAGNOSTICS INC
Shares:
802
Value:
$135.7M
DEXCOM INC
Shares:
1962
Value:
$134.0M
SIMILARWEB LTD.
Shares:
16166(+0.0%)
Value:
$133.7M(-41.6%)
AMEREN CORP
Shares:
1308(-40.5%)
Value:
$131.3M(-33.0%)
GLOBUS MEDICAL INC
Shares:
1747
Value:
$127.9M
VERTEX PHARMACEUTICALS INC / MA
Shares:
255
Value:
$123.6M
STERIS plc
Shares:
533
Value:
$120.8M
GILEAD SCIENCES, INC.
Shares:
1078
Value:
$120.8M
BECTON DICKINSON & CO
Shares:
517
Value:
$118.4M
Global Business Travel Group, Inc.
Shares:
15442(-44.3%)
Value:
$112.1M(-56.4%)
Immunome Inc.
Shares:
14164
Value:
$95.3M
N72482206
Shares:
2345
Value:
$94.2M
Medtronic plc
Shares:
1007
Value:
$90.5M
MYR GROUP INC.
Shares:
719(+16.3%)
Value:
$81.3M(-11.6%)
ESTABLISHMENT LABS HOLDINGS INC.
Shares:
1975
Value:
$80.6M
Structure Therapeutics Inc.
Shares:
4247(+310.7%)
Value:
$73.5M(+162.2%)
Ultragenyx Pharmaceutical Inc.
Shares:
1568
Value:
$56.8M
Certara, Inc.
Shares:
5442(+0.0%)
Value:
$53.9M(-7.0%)